Skip to main content
HR 2452 114th Congress House

To amend the Federal Food, Drug, and Cosmetic Act with respect to facilitating dissemination of health care economic information.

Introduced: May 19, 2015 See on congress.gov
Health Drug safety, medical device, and laboratory regulationHealth information and medical records
Sign in to write a letter Sign in to watch
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 22, 2015
Referred to the Subcommittee on Health.
May 19, 2015
Referred to the House Committee on Energy and Commerce.
May 19, 2015
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action May 22, 2015

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

This bill amends the Federal Food, Drug, and Cosmetic Act to revise the requirements for health care economic information that is provided to entities selecting drugs for coverage or reimbursement, such as formularies. The information must include a conspicuous and prominent statement describing the differences between the information and the labeling approved for the drug.

"Health care economic information" is an analysis that describes the economic consequences of the use of a drug. Such an analysis is no longer required to compare the use of the drug to another intervention or no intervention. An analysis that relates only to an indication for which the drug is not approved is not health care economic information.
 Related & companion bills 2
  • HR 6 Related bill 21st Century Cures Act
  • HR 34 Related bill 21st Century Cures Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2452: To amend the Federal Food, Drug, and Cosmetic Act with respect to facilitating dissemination of health care economic information.. 114th Congress. Open America. https://openamerica.io/bill/114-HR-2452/
MLA
"H.R. 2452: To amend the Federal Food, Drug, and Cosmetic Act with respect to facilitating dissemination of health care economic information.." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-2452/.
Bluebook (legal)
H.R. 2452, 114th Cong. (2026), https://openamerica.io/bill/114-HR-2452/.
Markdown link
[H.R. 2452: To amend the Federal Food, Drug, and Cosmetic Act with respect to facilitating dissemination of health care economic information.](https://openamerica.io/bill/114-HR-2452/)
Report a problem